Hallgren Sara, Darnerud Per Ola
Department of Pharmaceutical Biosciences, Division of Toxicology, Uppsala University, P.O. Box 594, Uppsala, Sweden.
Toxicology. 2002 Aug 15;177(2-3):227-43. doi: 10.1016/s0300-483x(02)00222-6.
The effects of the polybrominated diphenyl ether (PBDE) congener 2,2'4, 4'-tetrabromodiphenylether (DE-47), and technical preparations of polychlorinated biphenyls (PCBs; Aroclor 1254) and chlorinated paraffins (CPs; Witaclor 171P) on thyroid hormone (TH) levels were examined in rats. To study possible interactive effects, also combinations of the three compounds were used. Thus, female Sprague-Dawley rats, 7 weeks old, were treated with approximately isomolar doses (ca. 30 micromol/kg bw per day) of DE-47 (6.0 mg/kg per day), Aroclor 1254 (4.0 mg/kg per day) and Witaclor 171P (6.8 mg/kg per day), alone or in combinations, daily for 14 days by gastric intubation. DE-47 was also administered in a higher (18 mg/kg per day) and lower (1.0 mg/kg per day) dose. In order to test possible mechanisms behind the TH effects, microsomal enzyme (cytochrome P-450 isozymes and uridine diphosphoglucuronyl transferase-UDPGT) activity (indicating both metabolic activation and/or biliary clearance), ex vivo-binding of 125I-T4 to plasma proteins (suggesting effects on peripheral TH transport) and light microscope morphology of the thyroid gland were studied. The observed degree of TH reduction after Aroclor 1254 and DE-47 exposure corresponded with a decrease in the ex vivo binding of 125I-T4 to the plasma TH-transporter transthyretin (TTR), and with induction of the microsomal phase I enzymes (ethoxy- and methoxy-resorufin dealkylases, EROD and MROD). The phase II enzyme UDPGT was also elevated, but only moderately. The thyroid morphology showed an activation of the epithelia, but no degenerative alternations, that was correlated to exposure to Aroclor 1254. In our model, the observed effects match the hypothesis that the T4 decrease is chiefly due to disturbances in serum transport, caused by binding of in vivo-formed Aroclor 1254 and DE-47 metabolites to TTR. However, decreased plasma TH levels due to increased glucuronidation activity may also be of some importance. The thyroid gland hyperactivity is probably a feed-back consequence of the T4 decrease, in spite of the lack of TSH alterations. In the mixed DE-47 and Witaclor 171P group synergistic effects were indicated on free T4 (FT4) and EROD induction levels, results that may suggest that such effects should be considered in risk assessment of mixtures of persistent organohalogens.
在大鼠中研究了多溴二苯醚(PBDE)同系物2,2',4,4'-四溴二苯醚(DE-47)、多氯联苯(PCBs;Aroclor 1254)技术制剂和氯化石蜡(CPs;Witaclor 171P)对甲状腺激素(TH)水平的影响。为了研究可能的交互作用,还使用了这三种化合物的组合。因此,对7周龄的雌性斯普拉格-道利大鼠经口灌胃,每天单独或联合给予大约等摩尔剂量(约30微摩尔/千克体重/天)的DE-47(6.0毫克/千克/天)、Aroclor 1254(4.0毫克/千克/天)和Witaclor 171P(6.8毫克/千克/天),持续14天。DE-47也以较高(18毫克/千克/天)和较低(1.0毫克/千克/天)剂量给药。为了测试TH效应背后可能的机制,研究了微粒体酶(细胞色素P-450同工酶和尿苷二磷酸葡萄糖醛酸基转移酶-UDPGT)活性(表明代谢活化和/或胆汁清除)、125I-T4与血浆蛋白的体外结合(表明对周围TH转运的影响)以及甲状腺的光学显微镜形态。在暴露于Aroclor 1254和DE-47后观察到的TH降低程度与125I-T4与血浆TH转运蛋白甲状腺素结合蛋白(TTR)的体外结合减少以及微粒体I相酶(乙氧基和甲氧基试卤灵脱烷基酶,EROD和MROD)的诱导有关。II相酶UDPGT也升高,但仅为适度升高。甲状腺形态显示上皮细胞活化,但无退行性改变,这与暴露于Aroclor 1254有关。在我们的模型中,观察到的效应符合以下假设,即T4降低主要是由于体内形成的Aroclor 1254和DE-47代谢产物与TTR结合导致血清转运紊乱。然而,由于葡萄糖醛酸化活性增加导致的血浆TH水平降低也可能具有一定重要性。尽管促甲状腺激素(TSH)没有改变,但甲状腺功能亢进可能是T4降低的反馈结果。在DE-47和Witaclor 171P混合组中,游离T4(FT4)和EROD诱导水平显示出协同效应,这些结果可能表明在持久性有机卤素混合物的风险评估中应考虑此类效应。